Use of Ketamine in Clinical Practice: A Time for Optimism and Caution

Affiliations

¹ Center for Brain Research in Mood Disorders, Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St Louis, Missouri2Department of Neuroscience, Washington University School of Medicine, St Louis, Missouri.
² Center for Brain Research in Mood Disorders, Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St Louis, Missouri.

Comment

Charles F Zorumski et al. JAMA Psychiatry. 2017.

. 2017 Apr 1;74(4):405-406.

doi: 10.1001/jamapsychiatry.2017.0078.

¹ Center for Brain Research in Mood Disorders, Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St Louis, Missouri2Department of Neuroscience, Washington University School of Medicine, St Louis, Missouri.
² Center for Brain Research in Mood Disorders, Department of Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St Louis, Missouri.

No abstract available

Comment on

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. Sanacora G, et al. JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. JAMA Psychiatry. 2017. PMID: 28249076 Review.